Melanoma and Skin Cancer Trials
Paul White is an experienced director and risk management specialist with a robust background in governance and audit roles across multiple sectors. Since April 2015, Paul has led White Risk Solutions Pty Ltd, offering consulting services in risk training, framework design, and compliance management. Current engagements include serving as an Independent Member of the Finance, Risk & Audit Committee at the Melanoma and Skin Cancer Trials and as a Member of the Independent Audit Committee for the Office of Public Prosecutions in Victoria. Paul has also contributed to the Reserve Bank of Australia in roles focused on risk transformation and internal audits. Additional board experiences encompass VicTrack and Melanoma Research Victoria, alongside interim leadership positions in risk and compliance at State Trustees and Melbourne Convention and Exhibition Centre. Paul holds a Bachelor of Business in Accounting from Swinburne University of Technology and completed the Company Directors Course at the Australian Institute of Company Directors.
This person is not in the org chart
This person is not in any teams
Melanoma and Skin Cancer Trials
Melanoma and Skin Cancer Trials Limited (MASC Trials) is Australia and New Zealand’s collaborative clinical trials group committed to improving melanoma and skin cancer outcomes. Working with leading researchers, MASC Trials conducts multicentre, national and international clinical trials at more than 110 institutions in Australia and overseas. Our diverse and growing portfolio includes research in the prevention, early detection and treatment of melanoma and skin cancer, including early to late phase clinical trials. Our 2,250+ members throughout Australia and around the world represent the many disciplines critical to our work and strengthen the success of our clinical trials. Together, we work to reduce the burden of melanoma and skin cancer on the healthcare system. From early engagement with consumers and researchers to develop research ideas, through to the publication of results, we work cooperatively to provide a range of clinical trial services. We value the experiences of consumers and our collaborative approach ensures their unique perspectives are considered in clinical trial prioritisation and development. MASC Trials continues to be supported by the Australian Government via Cancer Australia, Monash University and the generosity of our corporate partners and donors. The high-quality evidence published from our trials changes clinical practice to impact the lives of patients and improve how doctors prevent, diagnose and treat melanoma and skin cancer. MASC Trials Ltd is registered as a charity with the Australian Charity and Not-for Profits Commission.